Study of Prevention of Postoperative Delirum to Reduce Incidence of Postoperative Cognitive Dysfunction
DelPOCD
The Influence of Non-medication-based Prophylaxis of Postoperative Delirium on Postoperative Delirium and Cognitive Deficit
1 other identifier
interventional
638
1 country
1
Brief Summary
Postoperative cognitive dysfunction describes a condition where cognitive functions such as attention, perception, concentration, learning, abstract thinking and problem solving are impaired postoperatively. These changes can be resolved after weeks and months, but in some cases may be permanent. The aetiology is multifactorial. One risk factor for developing POCD is the occurrence of postoperative delirium. A total of 638 consecutive patients will be enrolled in the study. Patients will be followed up at 7 days, 3 months and 1 year postoperatively. The cognitive function will be tested and compared to tests done before surgery. Postoperatively (from the day of operation until the 7th day and except of day 6) the grade of sedation; agitation; signs of delirium; pain; cardiac; respiratory; renal and infectious complications will be recorded. As possible influencing factors, the investigators will document diagnosed depression; comorbidities; intraoperative blood loss; length of hospital stay; 1-year-mortality; number of operations/anaesthetics undergone after the initial operation. Parameters that could trigger either depressive symptoms, neurocognitive dysfunction, anxiety, fatigue or lack of concentration will be recorded. These include: anaemia, hypercalcaemia, thyroidal gland hormones, electrolytes, creatinine, urea, glomerular filtration rate, cortisone therapy and adrenal cortical insufficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 16, 2014
CompletedFirst Posted
Study publicly available on registry
February 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedOctober 26, 2021
October 1, 2021
4 years
June 16, 2014
October 24, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative cognitive deficit (POCD)
measured by neuropsychological test battery, analysis
change from baseline in cognitive function at day 7, 3 months and 1 year after operation
Secondary Outcomes (8)
incidence and severity of postoperative delirium
from the day of operation until the 7th postoperative day
number of patients with cardiac complications
day of operation until 7th postoperative day
length of hospital stay
from day of admission until day of discharge, up to 24 weeks
mortality
1 year
health related quality of life
3 months, 1 year after operation
- +3 more secondary outcomes
Other Outcomes (4)
anxiety and depressive symptoms on HADS-D
7 days, 3 months, 1 year after operation
postoperative pain scores on the numeric rating scale (NRS)
day of operation until 7th postoperative day, 3 months, 1 year after operation
haemoglobin (Anaemia) on a score
intraoperative
- +1 more other outcomes
Study Arms (2)
monitoring and non-medical prophylaxis of delirium
OTHERThe treatment group will receive monitoring and prophylaxis of delirium. The study arm designed to prevent delirium incorporates reorientation (watches, calendar, family photos, use of hearing aids, glasses and dentures, cognitive stimulation (newspaper, magazines, radio, television), early mobilisation, early enteral nutrition, early removal of drains or catheters, normalizing sleep-awake-rhythm.
Standard
NO INTERVENTIONThe standard group will receive standard monitoring and standard treatment. The indication, choice and dosage of the medication used to treat delirium will be at the discretion of the ward doctor and will not be influenced by this study. The chosen medication as well as its dosage will be documented.
Interventions
Eligibility Criteria
You may qualify if:
- Age \> 60 years
- Cardiac surgery (on-pump/off-pump, standard/minimal invasive)
- Written informed patient's consent
You may not qualify if:
- Non-German speaking or not their first language
- Illiteracy
- Mental disability
- Non-corrigible vision impairment
- Non-corrigible hearing impairment
- Illegal substance abuse (current or past history)
- Alcohol abuse (current or past history)
- Chronic benzodiazepine use
- Psychosis (current or past history)
- Parkinson Disease
- Dementia
- Multiple sclerosis
- Epilepsy (current or past history)
- Cerebral tumor (current or past history)
- Apoplexy or intracranial bleeding (current or past history)
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anaesthesiology and Intensive Care Medicine, University Hospital Hamburg Eppendorf, Univ.-Prof. Dr. med. Alwin E. Goetz and Prof. Dr. med. Christian Zoellner
Hamburg, 20246, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2014
First Posted
February 23, 2017
Study Start
May 1, 2014
Primary Completion
May 1, 2018
Study Completion
May 1, 2021
Last Updated
October 26, 2021
Record last verified: 2021-10